Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Philips has become aware of an issue affects all piic ix surveillance and patient link revisions. the issue will occur after a surveillance station is first restarted during the year 2018. after that initial restart the station will thereafter no longer perform patient discharge and transfer operations. subsequent application restarts will occur when any of the following operations are performed: -discharging a patient under certain conditions -transferring a patient (from bedside or central station) -resolving patient conflicts (from bedside or central station) where bedside's patient must overwrite piic ix's patient (revision b.0x and c.0x only) -clearing a surveillance sector -assigning a bed to an empty surveillance sector the surveillance station will continue to monitor patients after any restart. (for french translation please see e-file).